Calorie restriction and body temperature: the NO-opioid dyad drops the “heat”

Scientists have known for some time that restricting calorie intake in laboratory animals can extend their lifespan and reduce their risk of developing diseases of older age, such as cancer, heart disease, diabetes, and Alzheimer’s disease. Some studies suggest that calorie restriction may have health benefits for humans, too. However, achieving and maintaining a calorie restricted diet is challenging for the vast majority of people. Identifying a drug that can mimic the metabolic effects of calorie restriction has, therefore, been an important goal of research into life extension. One of the striking effects of calorie restriction is that it leads to a fall in core body temperature. However, it has been unclear what contribution this makes to the diet’s health benefits. Some research does suggest that the reduction in core temperature contributes to the diet’s beneficial effects and is not simply a side effect. Mice engineered to have a lower core body temperature live longer than normal mice, for example, regardless of whether their calorie intake is restricted.

Other studies have found that people with a naturally low body temperature tend to live longer compared with those whose core temperature is closer to the norm for humans. Prof. Bruno Conti, PhD, of the Scripps Research Institute in La Jolla, CA, indeed commented: “It’s not easy to discern what’s driving the beneficial changes of calorie restriction. Is it the reduced calories on their own or the change in body temperature that typically happens when one consumes fewer calories? Or is it a combination of both?”. To identify chemicals that might contribute to these health benefits, Prof. Conti and his colleagues compared the metabolites — products of metabolism — of mice housed at 22°C with those living in 30°C conditions. The researchers fed all of the mice a calorie restricted diet. At 30°C, the bodies of both mice and humans reach the so-called “thermoneutrality.” At this point, their internal temperature balances the ambient temperature, making it difficult to reduce body temperature.

Scientists believe that thermoneutral conditions reduce some of the health benefits of calorie restriction. Therefore, Prof. Conti and his team reasoned that comparing calorie restricted mice housed at these different temperatures would reveal the metabolites responsible not only for reducing body temperature but also for extending lifespan. Specifically, they analyzed levels of metabolites in the animals’ blood and their hypothalamus, which is the part of the brain responsible for regulating feeding behavior and body temperature. In comparison with mice allowed to eat as much as they wanted, calorie restriction induced the hypothalamus to produce larger quantities of a range of metabolites when the ambient temperature was 22°C — but not when it was 30°C. The researchers then used artificial intelligence to single out which of these metabolites were likely to be biologically relevant. Two metabolites in particular were nitric oxide, a endogenous gas that dilates blood vessels, and an opioid called Leu-enkephalin.

In further experiments on calorie restricted mice, they demonstrated that both chemicals play a role in temperature control. In particular, targeted injection of Leu-Enk in the hypothalamus let the body temperature drop. These metabolites, and others that the researchers identified, could provide pointers for developing drugs that offer people the life extending benefits of calorie restriction without the need to follow an arduous diet. The authors note that their experiments involved reducing the calorie intake of mice to 50% of their usual intake over a period of 8 days. This restriction is more extreme than the usual calorie restriction that scientists use in lifespan experiments (60% of usual intake or more). They write that further research will be necessary to confirm that milder, longer lasting diets have similar effects on metabolism. The entire study features now in the journal Science Signaling.

  • Edited By Dr. Gianfrancesco Cormaci, PhD, specialist in Clinical Biochemistry.

Scientific references

Guijas C et al. Sci Signal. 2020 Sep 8; 13(648):eabb2490. 

Cintron-Colon R et al. Curr Biol. 2019 Dec 16; 29(24):4291-99.

Cintron-Colon R et al. Temperature (Austin) 2019; 6(2):158-68.

0 0 vote
Article Rating
Informazioni su Dott. Gianfrancesco Cormaci 2450 Articoli
- Laurea in Medicina e Chirurgia nel 1998 (MD Degree in 1998) - Specialista in Biochimica Clinica nel 2002 (Clinical Biochemistry specialty in 2002) - Dottorato in Neurobiologia nel 2006 (Neurobiology PhD in 2006) - Ha soggiornato negli Stati Uniti, Baltimora (MD) come ricercatore alle dipendenze del National Institute on Drug Abuse (NIDA/NIH) e poi alla Johns Hopkins University, dal 2004 al 2008. - Dal 2009 si occupa di Medicina personalizzata. - Detentore di un brevetto sulla preparazione di prodotti gluten-free a partire da regolare farina di frumento immunologicamente neutralizzata (owner of a patent concerning the production of bakery gluten-free products, starting from regular wheat flour). - Responsabile del reparto Ricerca e Sviluppo per la società CoFood s.r.l. (leader of the R&D for the partnership CoFood s.r.l.) - Autore di un libro riguardante la salute e l'alimentazione, con approfondimenti su come questa condizioni tutti i sistemi corporei. - Autore di articoli su informazione medica, salute e benessere sui siti web salutesicilia.com e medicomunicare.it
Subscribe
Notificami

Questo sito usa Akismet per ridurre lo spam. Scopri come i tuoi dati vengono elaborati.

0 Commenti
Inline Feedbacks
View all comments